206 related articles for article (PubMed ID: 23675998)
1. Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
Kabata H; Satoh T; Kataoka M; Tamura Y; Ono T; Yamamoto M; Huqun ; Hagiwara K; Fukuda K; Betsuyaku T; Asano K
Respirology; 2013 Oct; 18(7):1076-82. PubMed ID: 23675998
[TBL] [Abstract][Full Text] [Related]
2. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.
Girerd B; Montani D; Eyries M; Yaici A; Sztrymf B; Coulet F; Sitbon O; Simonneau G; Soubrier F; Humbert M
Respir Res; 2010 Jun; 11(1):73. PubMed ID: 20534176
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses in a cohort of 191 pulmonary arterial hypertension patients.
Yang H; Zeng Q; Ma Y; Liu B; Chen Q; Li W; Xiong C; Zhou Z
Respir Res; 2018 May; 19(1):87. PubMed ID: 29743074
[TBL] [Abstract][Full Text] [Related]
4. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
Evans JD; Girerd B; Montani D; Wang XJ; Galiè N; Austin ED; Elliott G; Asano K; Grünig E; Yan Y; Jing ZC; Manes A; Palazzini M; Wheeler LA; Nakayama I; Satoh T; Eichstaedt C; Hinderhofer K; Wolf M; Rosenzweig EB; Chung WK; Soubrier F; Simonneau G; Sitbon O; Gräf S; Kaptoge S; Di Angelantonio E; Humbert M; Morrell NW
Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients.
Liu D; Liu QQ; Eyries M; Wu WH; Yuan P; Zhang R; Soubrier F; Jing ZC
Eur Respir J; 2012 Mar; 39(3):597-603. PubMed ID: 21737554
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.
Jang AY; Kim BG; Kwon S; Seo J; Kim HK; Chang HJ; Chang SA; Cho GY; Rhee SJ; Jung HO; Kim KH; Seo HS; Kim KH; Shin J; Lee JS; Kim M; Lee YJ; Chung WJ
PLoS One; 2020; 15(9):e0238698. PubMed ID: 32966279
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
10. BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
Liu D; Wu WH; Mao YM; Yuan P; Zhang R; Ju FL; Jing ZC
Circ Cardiovasc Genet; 2012 Oct; 5(5):511-8. PubMed ID: 22923421
[TBL] [Abstract][Full Text] [Related]
11. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
[TBL] [Abstract][Full Text] [Related]
12. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.
Austin ED; Phillips JA; Cogan JD; Hamid R; Yu C; Stanton KC; Phillips CA; Wheeler LA; Robbins IM; Newman JH; Loyd JE
Respir Res; 2009 Sep; 10(1):87. PubMed ID: 19785764
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Characterization of
Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
[TBL] [Abstract][Full Text] [Related]
14. BMPR2 mutations found in Japanese patients with familial and sporadic primary pulmonary hypertension.
Morisaki H; Nakanishi N; Kyotani S; Takashima A; Tomoike H; Morisaki T
Hum Mutat; 2004 Jun; 23(6):632. PubMed ID: 15146475
[TBL] [Abstract][Full Text] [Related]
15. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
[TBL] [Abstract][Full Text] [Related]
17. Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.
Zhu N; Gonzaga-Jauregui C; Welch CL; Ma L; Qi H; King AK; Krishnan U; Rosenzweig EB; Ivy DD; Austin ED; Hamid R; Nichols WC; Pauciulo MW; Lutz KA; Sawle A; Reid JG; Overton JD; Baras A; Dewey F; Shen Y; Chung WK
Circ Genom Precis Med; 2018 Apr; 11(4):e001887. PubMed ID: 29631995
[TBL] [Abstract][Full Text] [Related]
18. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.
Girerd B; Coulet F; Jaïs X; Eyries M; Van Der Bruggen C; De Man F; Houweling A; Dorfmüller P; Savale L; Sitbon O; Vonk-Noordegraaf A; Soubrier F; Simonneau G; Humbert M; Montani D
Chest; 2015 May; 147(5):1385-1394. PubMed ID: 25429696
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.
Abou Hassan OK; Haidar W; Nemer G; Skouri H; Haddad F; BouAkl I
BMC Med Genet; 2018 May; 19(1):89. PubMed ID: 29843651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
